Safety and efficacy of daratumumab monotherapy in lupus nephritis refractory to conventional and rescue therapies

被引：0
|
作者：
Roccatello, Dario
Caniggia, Ilaria
Ceruti, Cecilia
Longo, Roberta
Nescis, Lorenzo
Sciascia, Savino
Fenoglio, Roberta
机构：
[1] Univ Ctr Excellence Nephrol Rheumatol & Rare Dis, Nephrol & Dialysis Unit, Turin, Italy
[2] Univ Ctr Excellence Nephrol Rheumatol & Rare Dis, Ctr Immuno Rheumatol & Rare Dis CMID, Turin, Italy
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
10.1093/ndt/gfae069.364
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
#2244
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of daratumumab monotherapy in lupus nephritis refractory to conventional and rescue therapies
    Roccatello, Dario
    Caniggia, Ilaria
    Ceruti, Cecilia
    Longo, Roberta
    Nescis, Lorenzo
    Sciascia, Savino
    Fenoglio, Roberta
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I612 - I612
  • [2] Daratumumab monotherapy for refractory lupus nephritis
    Dario Roccatello
    Roberta Fenoglio
    Ilaria Caniggia
    Joelle Kamgaing
    Carla Naretto
    Irene Cecchi
    Elena Rubini
    Daniela Rossi
    Emanuele De Simone
    Giulio Del Vecchio
    Martina Cozzi
    Savino Sciascia
    Nature Medicine, 2023, 29 : 2041 - 2047
  • [3] Daratumumab monotherapy for refractory lupus nephritis
    Roccatello, Dario
    Fenoglio, Roberta
    Caniggia, Ilaria
    Kamgaing, Joelle
    Naretto, Carla
    Cecchi, Irene
    Rubini, Elena
    Rossi, Daniela
    De Simone, Emanuele
    Del Vecchio, Giulio
    Cozzi, Martina
    Sciascia, Savino
    NATURE MEDICINE, 2023, 29 (08) : 2041 - +
  • [4] The efficacy and safety of cyclosporin A in refractory lupus nephritis.
    Ikeuchi, Hidekazu
    Kuroiwa, Takashi
    Sakurai, Noriyuki
    Kaneko, Yoriaki
    Hiromura, Keiju
    Nojima, Yoshihisa
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S436 - S437
  • [5] Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy
    Tanaka, Yoshiya
    Takeuchi, Tsutomu
    Miyasaka, Nobuyuki
    Sumida, Takayuki
    Mimori, Tsuneyo
    Koike, Takao
    Endo, Kazuhiro
    Mashino, Naomi
    Yamamoto, Kazuhiko
    MODERN RHEUMATOLOGY, 2016, 26 (01) : 80 - 86
  • [6] SYSTEMATIC REVIEW OF EFFICACY AND SAFETY OF BIOLOGICAL THERAPIES IN LUPUS NEPHRITIS
    Salgado, E.
    Rosario, M. P.
    Loza Santamaria, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 900 - 900
  • [7] Efficacy and safety of bortezomib in refractory lupus nephritis: a single-center experience
    Segarra, A.
    Arredondo, K. V.
    Jaramillo, J.
    Jatem, E.
    Salcedo, M. T.
    Agraz, I.
    Ramos, N.
    Carnicer, C.
    Valtierra, N.
    Ostos, E.
    LUPUS, 2020, 29 (02) : 118 - 125
  • [8] EFFICACY AND SAFETY OF ABATACEPT IN LUPUS NEPHRITIS
    Furie, R.
    Nicholls, K.
    Cheng, T. T.
    Houssiau, F.
    Burgos-Vargas, R.
    Chen, S. L.
    Hillson, J.
    Meadows-Shropshire, S.
    Kinaszczuk, M.
    Merrill, J. T.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 534 - 534
  • [9] Efficacy and safety of rituximab in comparison with common induction therapies in pediatric active lupus nephritis
    Biswanath Basu
    Birendranath Roy
    Binu George Babu
    Pediatric Nephrology, 2017, 32 : 1013 - 1021
  • [10] Efficacy and safety of rituximab in comparison with common induction therapies in pediatric active lupus nephritis
    Basu, Biswanath
    Roy, Birendranath
    Babu, Binu George
    PEDIATRIC NEPHROLOGY, 2017, 32 (06) : 1013 - 1021
12345